BV Cyclotron

BV Cyclotron VU is a leading Dutch specialty pharmaceutical company and CDMO specializing in the production of radiopharmaceuticals and radionuclides for medical diagnostics and research. Founded in 1987 as an independent spin-off from Vrije Universiteit Amsterdam, the company operates state-of-the-art GMP facilities and three high-capacity cyclotrons within the Amsterdam UMC Imaging Center. Their portfolio includes market-leading tracers such as Fludeoxyglucose (18F), PYLCLARI (piflufolastat 18F), and Zirconium-89, which are used globally for PET and SPECT imaging in oncology, neurology, and cardiology. BV Cyclotron VU serves as a critical manufacturing partner for major pharmaceutical firms like Curium and Revvity, delivering over 100,000 patient doses annually. The company is committed to advancing nuclear medicine through continuous investment in research and development and strategic academic collaborations.